Rochester, NY (PRWEB) May 19, 2014
Epstein-Barr virus (EBV) infection is associated with multiple sclerosis (MS). One recent study found that “Patients with multiple sclerosis (MS) have elevated antibodies against Epstein-Barr virus (EBV).” (See the Journal of Neuroimmunology, from April 16, 2014) (2). Research also shows high levels of latently infected cells in MS patients. In another recent study, “MS patients and controls were examined for their B-cell subsets and during 16 weeks for spontaneous lymphocyte transforming events. MS patients had normal distribution of B-cell subsets, but a significantly higher incidence of B-cell transforming events, which occurred with kinetics similar to controls. The higher incidence suggests an increased frequency of latent EBV-infected B cells in MS. (1).” polyDNA recommends that patients with MS talk to their doctors about Gene-Eden-VIR and Novirin. The formula of these natural antiviral products was designed to help the immune system target the latent Epstein Barr Virus.
Dr. Oz notes that “People with MS have a faulty immune response that causes immune cells to mistakenly attack the protective insulation (myelin) surrounding nerve fibers. When the myelin sheath is stripped it interferes with the transmission of nerve messages throughout the body and brain causing a wide range of neurological problems depending on where the damage occurs.” (See DoctorOz.com, from February 16, 2010) (3). According to the Dr. Oz website, “There are a few things that link the MS to EBV infections (3).” These include the following facts: “Nearly everyone with MS tests positive for EBV, people clear of the virus don't get the disease, high levels of EBV antibodies precede MS symptoms and flare-ups, and infectious mononucleosis doubles the risk for MS (3).”
What can infected people do against the EBV?
A few antiviral drugs are available that were shown to inhibit EBV replication in cell culture. These drugs include the acyclic nucleoside analogues aciclovir, ganciclovir, penciclovir, and their respective prodrugs valaciclovir, valganciclovir and famciclovir, the acyclic nucleotide analogues cidofovir and adefovir, and the pyrophosphate analogue foscarnet. However, clinical studies have shown that these drugs are mostly ineffective in humans. (See Pharmacology & Pharmacy, from September 2013) (4).
There are, however, some natural antiviral products that were shown to reduce EBV symptoms in two separate post-marketing clinical studies that followed FDA guidelines. These products are Gene-Eden-VIR and Novirin.
Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality, more expensive ingredients. The Novirin/Gene-Eden-VIR formula was tested in two post-marketing clinical studies published in September 2013 and March 2014, respectively, in the peer reviewed medical journal Pharmacy & Pharmacology (4).
Interested individuals can view the two published studies here, http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.
Up to 70% of those studied reported a decrease in symptoms associated with EBV infection, and users of the Novirin/Gene-Eden-VIR formula experienced an increase in overall health (4).
Each ingredient of Gene-Eden-VIR and Novirin was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the highest quality, safest, most effective natural ingredients that target latent viruses.
A second clinical study showed that the Novirin/Gene-Eden-VIR formula decreased physical and mental fatigue. (See Pharmacology & Pharmacy, from March, 2014) (5).
All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
“We recommend that individuals ask their doctors for an EBV blood test. If positive, they should talk to their doctors about Gene-Eden-VIR and Novirin. The formula of these natural products was proven to reduce EBV symptoms in a post-marketing clinical study that followed FDA guidelines.” – Mike Evans, polyDNA
(1) Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis. Published on March 31, 2014.
(2) Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1. Published on April 16, 2014.
(3) The Secret Life of the Epstein-Barr Virus. Published on February 16, 2010.
(4) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.http://www.cbcd.net/Gene-Eden-VIR-Clinical-Study.php
(5) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014. http://www.cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Novirin, an antiviral natural remedy that helps the immune system kill latent viruses.